Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation

Pharmacology

Volumn 80, Issue 1, 2007, Pages 49-56

  Lisboa, Sabrina F S ^a   Oliveira, Paulo E ^a   Costa, Leandro C ^a   Venâncio, Emerson J ^a   Moreira, Estefânia G ^a,b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b NONE   (Brazil)

Author keywords

Aggressiveness; Anxiety; Depression; Developmental exposure; Fluoxetine; Lactation; Pain sensitivity; Pregnancy

Indexed keywords

DAFORIN; FLUOXETINE; UNCLASSIFIED DRUG;

AGGRESSIVENESS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BEHAVIORAL STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED SWIMMING TEST; HOT PLATE TEST; IMMOBILIZATION; IMPULSIVENESS; LACTATION; MALE; MAZE TEST; MOUSE; NEUROTOXICITY; NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; FEMALE; FLUOXETINE; LACTATION; MALE; MICE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOMATOSENSORY DISORDERS;

EID: 34347347116     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103097     Document Type: Article

References (44)

1. Burt VK, Stein K: Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002;63:9-15.
2. Sloan DM, Kornstein SG: Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003;26:581-594.
3. McElhatton PR: Drug use in pregnancy. Part 1. Pharm J 2003;270:270-272.
4. Evans J, Heron J, Francomb H, Oke S, Golding J: Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001;323:257-260.
5. Zeskind PS, Stephens LE: Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368-375.
6. American Academy of Pediatrics Committee on Drugs: Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 2000;105:880-887.
7. Einarson A, Koren G: New antidepressants in pregnancy. Can Fam Physician 2004;50:227-229.
8. Pohland RC, Byrd TK, Hamilton M, Koons JR: Placental transfer and fetal distribution of fluoxetine in the rat. Toxicol Appl Pharmacol 1989;98:198-205.
9. Hendrick V, Stowe ZN, Altshuler LL, Mintz J, Hwang S, Hostetter A, et al: Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;50:775-782.
10. Lauder JM: Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 1993;16:233-240.
11. Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM: Serotonin as a developmental signal. Behav Brain Res 1996;73:19-29.
12. De Ceballos ML, Benedi A, Urdin C, Del Rio J: Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex: lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour. Neuropharmacology 1985;24:947-952.
13. Jason KM, Cooper TB, Friedman E: Prenatal exposure to imipramine alters early behavioral development and beta adrenergic receptors in rats. J Pharmacol Exp Ther 1981;217:461-466.
14. Ansorge MS, Zhou M, Lira A, Hen R, Gingrish JA: Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306:879-881.
15. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH: Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 1998;95:15049-15054.
16. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M: Increased anxiety of mice lacking the serotonin 1A receptor. Proc Natl Acad Sci USA 1998;95:10734-10739.
17. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelson M: Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 1998;95:14476-14481.
18. Bairy KL, Madhyastha S, Ashok KP, Bairy I, Malini S: Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2006;79:1-11.
19. Hoyt JA, Byrd RA, Brophy GT, Markham JK: A reproduction study of fluoxetine hydrochloride administered in the diet to rats. Teratology 1989;39:459-465.
20. Vorhees CV, Acuff-Smith KD, Schilling MA, Fisher E, Moran MS, Buelke-Sam J: A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam Appl Toxicol 1994;23:194-205.
21. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RCS, Paul IA: Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006;31:47-57.
22. Organization for Economic Co-operation and Development: OECD Guideline for the Testing of Chemicals. Developmental Neurotoxicity Study 426. pp. 1-20, Organization for Economic Co-operation and Development, 2003.
23. Broadhurst PL: Experiments in psychogenetics; in Eysenk HJ (ed): Experiments in Personality. London, Rutledge and Kegan Paul, 1960, pp 31-61.
24. Porsolt RD, Le Pichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-732.
25. Lister RG: The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987;92:180-185.
26. Olivier B, Mos J, Van Oorschot R, Hen R: Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 1995;28:80-90.
27. Eddy NB, Leimbach D: Synthetic analgesics. 2. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther 1953;107:385-393.
28. Byrd RA, Markham JK: Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits. Fundam Appl Toxicol 1994;22:511-518.
29. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH: Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995;378:383-386.
30. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R: Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999;21:S52-S60.
31. Willner P: The validity of animal models of depression. Psychopharmacology 1984;83:1-16.
32. Hansen HH, Sanchez C, Meier E: Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 1997;283:1333-1341.
33. Mendes-da-Silva C, Souza SL, Barreto-Medeiros JM, Freitas-Silva SR, Antunes DEC, Cunha ADU, et al: Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats. Arq Neuropsiquiatr 2002;60:928-931.
34. Manhães de Castro R, Barreto Medeiros JM, Mendes da Silva C, Ferreira LMP, Guedes RCA, Cabral Filho JE, Costa JA: Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor. Braz J Med Biol Res 2001;34:121-124.
35. Lauder JM, Liu J, Grayson DR: In utero exposure to serotoninergic drugs alters neonatal expression of 5-HT1A receptor transcripts: a quantitative RT-PCR study. Int J Dev Neurosci 2000;18:171-176.
36. Albert PR, Zhou QY, Van Tol HH, Bunzow JR, Civelli O: Cloning, functional expression and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 1990;265:5825-5832.
37. Daval G, Verge D, Becerril A, Gozlan H, Spampinato U, Hamon M: Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. Int J Dev Neurosci 1987;5:171-180.
38. Del Olmo E, Diaz A, Guirao-Pineyro M, Del Arco C, Pascual J, Pazos A: Transient localization of 5-HT1A receptors in human cerebellum during development. Neurosci Lett 1994;166:149-152.
39. Borella A, Brinda M, Whitaker-Azmitia PM: Role of the 5-HT1A receptor in development of the neonatal rat brain: preliminary behavioral studies. Neuropharmacology 1997;36:445-450.
40. Wilson CC, Faber KM, Haring JH: Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1A receptors: evidence for a glial mechanism. Brain Res 1998;782:235-239.
41. Yan W, Wilson CC, Haring JH: 5-HT1A receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res Dev Brain Res 1997;98:185-190.
42. Albert PR, Lemonde S: 5-HT1A receptors, gene repression and depression: guilt by association. Neuroscientist 2004;10:575-593.
43. Giammanco M, Tabacchi G, Giammanco S, Di Majo D, La Guardia M: Testosterone and aggressiveness. Med Sci Monit 2005;11:RA136-RA145.
44. Nelson RJ, Chiavegatto S: Molecular basis of aggression. Trends Neurosci 2001;24:713-719.